Independence Blue Cross CEO named chairman of BCBSA board; Why U.S. drug costs are so high;

News From Around the Web

> Daniel J. Hilferty, president and CEO of Philadelphia-based Independence Blue Cross, has been elected chairman of the Blue Cross Blue Shield Association's board of directors. Announcement

> Vox offers an in-depth look at why prescription drug prices are so high in the United States as compared to other countries. Article

> The Centers for Medicare & Medicaid Services has released data on services provided to Medicare beneficiaries by home health agencies. Announcement

Healthcare News

> In an exclusive interview with FierceHealthcare, a leading executive search firm's chief quality officer talks about the need for children's hospitals to find leaders with non-healthcare experience who have successfully handled major transitions within their industries. Article

AntiFraud News

> A collaborative effort that included both public and private legal teams was a critical element in forcing Novartis into a $390 million settlement finalized last month, according to a Bloomberg BNA Q&A with one of the whistleblower attorneys involved in the case. Article

And finally… Festive and futuristic. Article

Suggested Articles

A judge has dismissed the ongoing case between Oscar Health and Blue Cross Blue Shield of Florida over broker arrangements.

Expanding options for dental care in Medicare is a popular idea, but policymakers could take several avenues toward this goal, a new analysis shows.

Tennessee's proposal for a block grant brings a host of questions.